跳至主要内容
临床试验/CTRI/2021/08/035522
CTRI/2021/08/035522尚未招募不适用

Incidence and Clinical Outcome of Congenital Heart Diseases in Tertiary Care Hospital-A Clinical Registry

Dr Krishnananda Nayak1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2021年8月13日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
500
试验地点
1
主要终点
The present study evaluates the spectrum epidemiology etiology clinical manifestations clinical outcome etc., of CHDs which helps to make a registry contributing to the incidence study of CHDs further

研究概览

简要总结

The present study evaluates the spectrum, epidemiology, etiology, clinical manifestations, clinical outcome etc. of CHDs.

Objective:To asses

  • The overall incidence of acyanotic and cyanotic heart diseases.
  • To analyse the pattern of clinical manifestations of various forms of congenital heart diseases of any age group.

研究设计

研究类型
Observational

入排标准

年龄范围
1.00 Day(s) 至 80.00 Day(s)(—)
性别
All

入选标准

  • 1.Acyanotic CHDs including (Bicuspid aortic valve, Shunt lesions, Obstructive, Regurgitation or miscellaneous lesions) 2.Cyanotic CHD i.With normal PBF ii.With increased PBF iii.With decreased PBF 3.Pericardial diseases (Congenital absent pericardium, Ectopia cordis etc.) 4.Others (Rhabdomyoma) 5.Arch anomalies 6.Aberrant arch vessels 7.Coronary anomalies 8.PAPVC.

排除标准

  • 1.PFO ( Patent foramen ovale) 2.Tiny closing PDA in <3 months of age 3.Silent PDA 4.Physiological flow acceleration across branch pulmonary arteries 5.Systemic venous anomalies (of non significant physiology like isolated LSVC) 6.Isolated PAPVC without any association with any CHD 7.Arrhythmias with a structurally normal heart 8.Diagnosed cases who have undergone any kind of intervention.

结局指标

主要结局

The present study evaluates the spectrum epidemiology etiology clinical manifestations clinical outcome etc., of CHDs which helps to make a registry contributing to the incidence study of CHDs further

时间窗: 5 years

次要结局

未报告次要终点

研究者

发起方
Dr Krishnananda Nayak
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验